about
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort studyThe family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER
P50
description
researcher (ORCID 0000-0002-6831-8205)
@en
wetenschapper
@nl
name
Yuichi Maeda
@en
Yuichi Maeda
@nl
type
label
Yuichi Maeda
@en
Yuichi Maeda
@nl
prefLabel
Yuichi Maeda
@en
Yuichi Maeda
@nl
P31
P496
0000-0002-6831-8205